Skip to main content

Table 1 Clinicopathologic variables of included ICC patients

From: Investigating effects of preoperative inflammatory biomarkers on predicting survival outcomes of intrahepatic cholangiocarcinoma after curative resection

Variables Values (n = 128)
Age (years) 56.19 ± 9.63
Male 70 (54.7)
Tumor size (cm) 5.83 ± 2.85
Number of tumors
 Single 92 (71.9)
 Multiple 36 (28.1)
AJCC tumor stage
 I 34 (26.6)
 II 19 (14.8)
 III 75 (58.6)
Lymph node metastasis
 No 84 (65.6)
 Yes 44 (34.4)
Vascular invasion
 No 77 (60.2)
 Yes 51 (39.8)
Tumor differentiation
 Well to moderate 44 (34.4)
 Poor to undifferentiated 84 (65.6)
ALT (U/L) 49.58 ± 57.93
AST (U/L) 42.51 ± 31.27
CEA (ng/ml) 6.96 ± 15.93
CA19-9 (U/ml) 272.69 ± 318.33
CA242 (U/ml) 75.56 ± 104.66
Neutrophil (109/L) 4.70 ± 1.91
Lymphocyte (109/L) 1.59 ± 0.49
Monocyte (109/L) 0.66 ± 0.87
PLT (109/L) 232.39 ± 97.68
Albumin (g/L) 40.33 ± 4.45
Child-Pugh score
 A 111 (86.7)
 B 17 (13.3)
NLR 3.30 ± 2.16
PLR 156.79 ± 77.66
LMR 3.20 ± 2.46
SII 793.67 ± 695.14
  1. Data are expressed as mean ± standard deviation or n (%)
  2. ICC intrahepatic cholangiocarcinoma, AJCC American Joint Committee on Cancer, ALT alanine aminotransferase, AST aspartate aminotransferase, CEA carcinoembryonic antigen, PLT blood platelet, NLR neutrophil-to-lymphocyte ratio, PLR platelet-to-lymphocyte ratio, LMR lymphocyte-to-monocyte ratio, SII systemic immune-inflammation index